(Q67212334)

English

Selegiline as the primary treatment of Parkinson's disease--a long-term double-blind study.

scholarly article by V V Myllylä et al published 1997 in Acta Neurologica Scandinavica

  • Selegiline as the primary treatment of Parkinson's disease - a long-term double-blind study

Statements

Selegiline as the primary treatment of Parkinson's disease--a long-term double-blind study. (English)
0 references
0 references
0 references
0 references
0 references
0 references
1997
0 references
95
1 reference
10 September 2019
4
1 reference
10 September 2019
211-218
1 reference
10 September 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit